로딩 중…
지수 로딩 중…
MoonLake Immunotherapeutics
MLTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CH
CH$19.21+0.10%
2026-06-18
Price Chart
MoonLake Immunotherapeutics-55.84%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.41B |
| Revenue | $0.00 |
| Net Income | $-257M |
| Total Assets | $400M |
| Net Assets | $254M |
| Value | |
| P/B | 5.57x |
| FCF Yield | -15.85% |
| Profitability | |
| ROE | -101.20% |
| ROA | -64.21% |
| Financial Health | |
| Debt Ratio | 57.61% |
| Total Debt | $101M |
| FCF | $-224M |
| Cash | $298M |
| Current Ratio | 8.60x |
| Performance | |
| 1Y Return | -55.84% |
| 1M Return | 17.35% |
| From 52W High | -69.39% |
| 1Y MDD | -89.92% |
| Trading | |
| Volume | 768,495 shares |
| Trading Value | $15M |
| Per Share | |
| EPS | $-3.53 |
| BPS | $4.72 |